Gil M. Labrucherie

2014

In 2014, Gil M. Labrucherie earned a total compensation of $3.2M as Senior Vice President and General Counsel at Nektar Therapeutics, a 119% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$396,000
Option Awards$2,312,379
Salary$526,125
Other$8,354
Total$3,242,858

Labrucherie received $2.3M in option awards, accounting for 71% of the total pay in 2014.

Labrucherie also received $396K in non-equity incentive plan, $526.1K in salary and $8.4K in other compensation.

Rankings

In 2014, Gil M. Labrucherie's compensation ranked 2,769th out of 13,032 executives tracked by ExecPay. In other words, Labrucherie earned more than 78.8% of executives.

ClassificationRankingPercentile
All
2,769
out of 13,032
79th
Division
Manufacturing
984
out of 4,965
80th
Major group
Chemicals And Allied Products
311
out of 1,690
82nd
Industry group
Drugs
242
out of 1,369
82nd
Industry
Pharmaceutical Preparations
199
out of 1,042
81st
Source: SEC filing on April 29, 2016.

Labrucherie's colleagues

We found four more compensation records of executives who worked with Gil M. Labrucherie at Nektar Therapeutics in 2014.

2014

Howard Robin

Nektar Therapeutics

Chief Executive Officer

2014

Ivan Gergel

Nektar Therapeutics

Chief Medical Officer

2014

John Nicholson

Nektar Therapeutics

Chief Financial Officer

2014

Stephen Doberstein

Nektar Therapeutics

Chief Scientific Officer

News

In-depth

You may also like